CS

China Summit Capital

Asia, Shanghai, China, Shanghai

Description

China Summit Capital is a private equity fund management firm that specializes in technological innovation.

Investor Profile

China Summit Capital has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (67%)
  • Series D (33%)

Country Focus

  • China (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Health Care
  • Medical Device
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does China Summit Capital frequently co-invest with?

Jiuyou Capital
Asia, Jilin, China, Guangdong
Co-Investments: 1
Nan Fung Life Sciences
North America, California, United States, San Francisco
Co-Investments: 1
B
Asia, Beijing, China, Beijing
Co-Investments: 1
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
PB
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CE
Asia, Fujian, China, Xiamen
Co-Investments: 1
Volcanics Venture
Asia, Shanghai, China, Changning
Co-Investments: 1
KB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1

Which angels does China Summit Capital often collaborate with?

SI
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by China Summit Capital?

IMPACT Therapeutics

Nanjing, Jiangsu, China

IMPACT Therapeutics is a therapeutics company dedicated to the development of similar drugs to treat cancer.

BiotechnologyPharmaceuticalTherapeutics
Series DMar 14, 2022
OncXerna Therapeutics

Waltham, Massachusetts, United States

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

BiopharmaBiotechnologyHealth CareMedical DevicePharmaceuticalPrecision Medicine
Series BJun 10, 2019
Amount Raised: $80,000,000
IMPACT Therapeutics

Nanjing, Jiangsu, China

IMPACT Therapeutics is a therapeutics company dedicated to the development of similar drugs to treat cancer.

BiotechnologyPharmaceuticalTherapeutics
Series BFeb 22, 2016
Amount Raised: $10,000,000